In the Sept/Oct 2015 Issue of American Pharmaceutical Review, Dr. Julie Quinn, Malvern Panalytical XRPD Product Manager for the Americas, was asked for her views on the importance of X-ray powder diffraction (XRPD) for the pharmaceutical industry, and how the latest advances in XRPD benefit pharmaceutical research.
In the Sept/Oct 2015 Issue of American Pharmaceutical Review, Dr. Julie Quinn, Malvern Panalytical XRPD Product Manager for the Americas, was asked for her views on the importance of X-ray powder diffraction (XRPD) for the pharmaceutical industry, and how the latest advances in XRPD benefit pharmaceutical research.
